VAXCYTE, INC. Other Non-Current Liabilities
VAXCYTE, INC. (PCVX) had Other Non-Current Liabilities of $100.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-02-24
- 2025-12-31: Other Liabilities, Noncurrent $100.00K.
- 2024-12-31: Other Liabilities, Noncurrent $100.00K.
- 2023-12-31: Other Liabilities, Noncurrent $0.00.
- 2023-09-30: Other Liabilities, Noncurrent $2.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-12-31 | $100.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | $100.00K 10-K · filed 2026-02-24 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-25 |
| 2023-09-30 | $2.00K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $5.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $7.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $9.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $89.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $92.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $93.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $96.00K 10-K · filed 2023-02-27 |
| 2021-09-30 | $98.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $100.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $103.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $112.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $128.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $136.00K 10-Q · filed 2020-08-12 |
| 2019-12-31 | $242.00K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |